Literature DB >> 20220163

Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia.

Rosa Bellmann-Weiler1, Mathias Ausserwinkler, Katharina Kurz, Igor Theurl, Guenter Weiss.   

Abstract

We retrospectively analyzed the records of 61 hospitalized patients with community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae or Legionella pneumophila. We found that serum procalcitonin and sodium concentrations were significantly lower, and ferritin levels were significantly higher, in patients infected with L. pneumophila than in those infected with S. pneumoniae. The ratio of C-reactive protein to procalcitonin significantly distinguished between the groups. High procalcitonin levels were associated with an adverse clinical course.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20220163      PMCID: PMC2863928          DOI: 10.1128/JCM.01348-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin.

Authors:  Michael S Niederman
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

Review 2.  Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network.

Authors:  Tobias Welte; Thomas Köhnlein
Journal:  Semin Respir Crit Care Med       Date:  2009-03-18       Impact factor: 3.119

3.  Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease.

Authors:  Jürgen H Helbig; Søren A Uldum; Sverker Bernander; Paul Christian Lück; Günther Wewalka; Bill Abraham; Valeria Gaia; Timothy G Harrison
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 4.  Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.

Authors:  John G Bartlett
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

5.  Prognostic value of procalcitonin in Legionella pneumonia.

Authors:  J Haeuptle; R Zaborsky; R Fiumefreddo; A Trampuz; I Steffen; R Frei; M Christ-Crain; B Müller; P Schuetz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-02       Impact factor: 3.267

6.  Performance of a pneumolysin enzyme-linked immunosorbent assay for diagnosis of pneumococcal infections.

Authors:  María del Mar García-Suárez; María Dolores Cima-Cabal; Roberto Villaverde; Emma Espinosa; Miquel Falguera; Juan R de Los Toyos; Fernando Vázquez; Francisco J Méndez
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

7.  Iron depletion limits intracellular bacterial growth in macrophages.

Authors:  Prasad N Paradkar; Ivana De Domenico; Nina Durchfort; Irene Zohn; Jerry Kaplan; Diane McVey Ward
Journal:  Blood       Date:  2008-03-27       Impact factor: 22.113

8.  Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection.

Authors:  Michael D Smith; Carmen L Sheppard; Angela Hogan; Timothy G Harrison; David A B Dance; Petra Derrington; Robert C George
Journal:  J Clin Microbiol       Date:  2009-02-18       Impact factor: 5.948

9.  The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium.

Authors:  Manfred Nairz; Igor Theurl; Susanne Ludwiczek; Milan Theurl; Sabine M Mair; Gernot Fritsche; Günter Weiss
Journal:  Cell Microbiol       Date:  2007-04-25       Impact factor: 3.715

10.  Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.

Authors:  Peter M Houck; Dale W Bratzler; Wato Nsa; Allen Ma; John G Bartlett
Journal:  Arch Intern Med       Date:  2004-03-22
View more
  7 in total

Review 1.  Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections.

Authors:  Hui Li; Yi-Feng Luo; Timothy S Blackwell; Can-Mao Xie
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

2.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

3.  Levels of serum procalcitonin and C-reactive protein for evaluating pulmonary bacterial infection in patients with lupus erythematosus.

Authors:  Jing Gao; Lei Zhang; Xin Zhang; Shi-Long Zhao; Sheng-Yun Liu; Li-Hua Xing
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

4.  Neopterin Predicts Disease Severity in Hospitalized Patients With COVID-19.

Authors:  Rosa Bellmann-Weiler; Lukas Lanser; Francesco Burkert; Stefanie Seiwald; Gernot Fritsche; Sophie Wildner; Andrea Schroll; Sabine Koppelstätter; Katharina Kurz; Andrea Griesmacher; Günter Weiss
Journal:  Open Forum Infect Dis       Date:  2020-11-03       Impact factor: 3.835

Review 5.  Advances in community-acquired pneumonia.

Authors:  Barbara Jones; Grant Waterer
Journal:  Ther Adv Infect Dis       Date:  2020-11-06

6.  Procalcitonin to C-reactive protein ratio is associated with short-term mortality in ischemic stroke patients: preliminary report.

Authors:  Jooyoung Cho; Seri Jeong; Jong-Han Lee
Journal:  Arch Med Sci       Date:  2020-10-23       Impact factor: 3.318

7.  Legionellosis and lung abscesses: contribution of legionella quantitative real-time PCR to an adapted followup.

Authors:  G Descours; C Tellini; C Flamens; F Philit; M Celard; J Etienne; G Lina; S Jarraud
Journal:  Case Rep Infect Dis       Date:  2013-06-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.